Cladribine Capsules(Merck)

克拉屈滨胶囊(默克)

Report date: 2025/12/05 17:17:11

Base Information

Drug NameCladribine Capsules(Merck)
Drug Alias Name2-Chlorodeoxyadenosine克拉曲滨Chlorodeoxyadenosine克拉屈宾Leustatine +[12
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunosuppressants
TargetsRibonucleotide reductase
Therapy Area/IndicationsMyasthenia Gravis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanGeorgia +[7
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesMerck Healthcare Kgaa
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMyasthenia Gravis
Inactive IndicationsN/A

Other Information

ATC CodeN/A